Jeffrey M LeidenFiled
Executive ChairmanExecutiveDirectorCIK 1242825
- VRTXVERTEX PHARMACEUTICALS INC / MAExecutive Chairmanfiled Feb 26, 2026
Net · 12 months
-$60.9M
Open-market buys − sales
Sold · 12 months
$60.9M
$0 in 90d · 24 sales on record
Bought · 12 months
$0
$0 in 90d · 0 buys on record
Under 10b5-1
100%
Share of sale value under a trading plan
Last trade
Feb 24, 2026
Filed Feb 26, 2026 · 48 rows
Monthly open-market value · 24 months Filed
- Bought (open market)
- Sold (open market)
Unusual activity Estimated
Whale score 95Whale watch
- 27Exec saleDec 3, 2025
VRTX Chair Jeffrey M Leiden sold $7.1M (10b5-1 plan)
Details
- Insider
- Jeffrey M Leiden
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Tx date
- Dec 3, 2025
- Shares
- 15,681
- Price
- $452
- Value
- $7.1M
- Is 10b5 1
- Yes
- 32Exec saleNov 14, 2025
VRTX Chair Jeffrey M Leiden sold $14.2M (10b5-1 plan)
Details
- Insider
- Jeffrey M Leiden
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Tx date
- Nov 14, 2025
- Shares
- 32,234
- Price
- $440
- Value
- $14.2M
- Is 10b5 1
- Yes
- 29Exec saleNov 14, 2025
VRTX Chair Jeffrey M Leiden sold $9.4M (10b5-1 plan)
Details
- Insider
- Jeffrey M Leiden
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Tx date
- Nov 14, 2025
- Shares
- 21,330
- Price
- $441
- Value
- $9.4M
- Is 10b5 1
- Yes
- 28Exec saleNov 13, 2025
VRTX Chair Jeffrey M Leiden sold $8.2M (10b5-1 plan)
Details
- Insider
- Jeffrey M Leiden
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Ticker
- VRTX
- Tx kind
- open_market_sale
- Tx date
- Nov 13, 2025
- Shares
- 18,528
- Price
- $440
- Value
- $8.2M
- Is 10b5 1
- Yes
Transactions
Independent third-party platform; not affiliated with or endorsed by any member of Congress. Data sourced from publicly available filings and records. Portfolio, holdings, returns, and allocations are estimates and may differ from actual values. Informational and educational only; not investment advice. Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4; the whale score is a model ranking of that filed activity.